News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
CSL Gets FDA Close Out Letter
August 24, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CSL Group has resolved the manufacturing problems it faced over the last 12 months to finish fiscal 2012 with higher revenue and profits.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Asia
Australia
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Layoff Tracker
Takeda Slashes US Headcount, Hitting Neuro Commercial Teams Hard
January 19, 2026
·
46 min read
·
BioSpace Editorial Staff
IPO
2026 IPO Train Keeps Chugging as AgomAb, SpyGlass Eye Nasdaq Debut
January 19, 2026
·
2 min read
·
Tristan Manalac
Obesity
Novo Rises as Oral Wegovy Reaches Over 3,000 Patients in First Week of Launch
January 19, 2026
·
1 min read
·
Tristan Manalac
Layoffs
Vedanta ‘Significantly’ Reduces Staff, Focuses on Phase III Study of
C. Diff
Drug
January 16, 2026
·
2 min read
·
Angela Gabriel
